ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
140.2 EUR
-0.2 (-0.14%)
Taking everything into account, ACT scores 7 out of 10 in our fundamental rating. ACT was compared to 70 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making ACT a very profitable company, without any liquidiy or solvency issues. ACT is not valued too expensively and it also shows a decent growth rate. These ratings could make ACT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
Each year in the past 5 years ACT has been profitable.
Of the past 5 years ACT 4 years had a positive operating cash flow.
1.2 Ratios
ACT has a better Return On Assets (10.49%) than 95.71% of its industry peers.
ACT has a better Return On Equity (26.47%) than 95.71% of its industry peers.
ACT's Return On Invested Capital of 13.45% is amongst the best of the industry. ACT outperforms 92.86% of its industry peers.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.86%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(13.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
Looking at the Profit Margin, with a value of 10.97%, ACT belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
In the last couple of years the Profit Margin of ACT has grown nicely.
ACT has a better Operating Margin (15.93%) than 85.71% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
With an excellent Gross Margin value of 66.55%, ACT belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.
ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
ACT has less shares outstanding than it did 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
ACT has a better debt/assets ratio than last year.
2.2 Solvency
ACT has an Altman-Z score of 4.79. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.79, ACT belongs to the top of the industry, outperforming 87.14% of the companies in the same industry.
The Debt to FCF ratio of ACT is 1.32, which is an excellent value as it means it would take ACT, only 1.32 years of fcf income to pay off all of its debts.
ACT has a better Debt to FCF ratio (1.32) than 94.29% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that ACT is not too dependend on debt financing.
The Debt to Equity ratio of ACT (0.16) is better than 72.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 4.79 |
ROIC/WACC1.9
WACC7.09%
2.3 Liquidity
ACT has a Current Ratio of 2.87. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.87, ACT belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
A Quick Ratio of 1.77 indicates that ACT should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.77, ACT belongs to the best of the industry, outperforming 81.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.12%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.05% in the past year.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
ACT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.26% yearly.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.6%
Revenue Next 5Y6.02%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.98 indicates a rather expensive valuation of ACT.
ACT's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.38. ACT is around the same levels.
With a Price/Forward Earnings ratio of 20.09, ACT is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as ACT.
ACT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.98 | ||
| Fwd PE | 20.09 |
4.2 Price Multiples
ACT's Enterprise Value to EBITDA ratio is in line with the industry average.
ACT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.79 | ||
| EV/EBITDA | 12 |
4.3 Compensation for Growth
ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 19.49% in the coming years.
PEG (NY)1.26
PEG (5Y)0.93
EPS Next 2Y17.04%
EPS Next 3Y19.49%
5. Dividend
5.1 Amount
ACT has a Yearly Dividend Yield of 1.28%.
ACT's Dividend Yield is slightly below the industry average, which is at 2.49.
ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.28% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
ACT pays out 49.16% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
FRA:ACT (12/19/2025, 7:00:00 PM)
140.2
-0.2 (-0.14%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners37.98%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.43B
Revenue(TTM)563.86M
Net Income(TTM)61.84M
Analysts81.82
Price Target158.56 (13.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.28% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP49.16%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.83%
PT rev (3m)-1.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.98 | ||
| Fwd PE | 20.09 | ||
| P/S | 2.53 | ||
| P/FCF | 40.79 | ||
| P/OCF | 9.81 | ||
| P/B | 6.11 | ||
| P/tB | 6.2 | ||
| EV/EBITDA | 12 |
EPS(TTM)6.1
EY4.35%
EPS(NY)6.98
Fwd EY4.98%
FCF(TTM)3.44
FCFY2.45%
OCF(TTM)14.3
OCFY10.2%
SpS55.39
BVpS22.95
TBVpS22.6
PEG (NY)1.26
PEG (5Y)0.93
Graham Number56.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROCE | 18.66% | ||
| ROIC | 13.45% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 16.26% | ||
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% | ||
| FCFM | 6.21% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.34% | ||
| Profit Quality | 56.58% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 4.79 |
F-Score6
WACC7.09%
ROIC/WACC1.9
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.6%
Revenue Next 5Y6.02%
EBIT growth 1Y16.7%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year50.23%
EBIT Next 3Y28.55%
EBIT Next 5Y19.11%
FCF growth 1Y37.23%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y166.77%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 22.98 and the Price/Book (PB) ratio is 6.11.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.